These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 36166145)

  • 1. Advanced therapeutic strategies targeting microglia: beyond neuroinflammation.
    Kwon MS
    Arch Pharm Res; 2022 Sep; 45(9):618-630. PubMed ID: 36166145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Role of Microglia in the Homeostasis of the Central Nervous System and Neuroinflammation].
    Gogoleva VS; Drutskaya MS; Atretkhany KS
    Mol Biol (Mosk); 2019; 53(5):790-798. PubMed ID: 31661478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods.
    Yoo HJ; Kwon MS
    Front Aging Neurosci; 2021; 13():766267. PubMed ID: 35069173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases.
    Russo C; Valle MS; Russo A; Malaguarnera L
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia Function in the Central Nervous System During Health and Neurodegeneration.
    Colonna M; Butovsky O
    Annu Rev Immunol; 2017 Apr; 35():441-468. PubMed ID: 28226226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taming microglia: the promise of engineered microglia in treating neurological diseases.
    Luo EY; Sugimura RR
    J Neuroinflammation; 2024 Jan; 21(1):19. PubMed ID: 38212785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
    Yousaf M; Chang D; Liu Y; Liu T; Zhou X
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders.
    Malek N; Gladysz R; Stelmach N; Drag M
    ACS Chem Neurosci; 2024 Jul; 15(14):2532-2544. PubMed ID: 38970802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of neuroinflammation for the repair of the injured central nervous system.
    Yong HYF; Rawji KS; Ghorbani S; Xue M; Yong VW
    Cell Mol Immunol; 2019 Jun; 16(6):540-546. PubMed ID: 30874626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanting Microglia for Treating CNS Injuries and Neurological Diseases and Disorders, and Prospects for Generating Exogenic Microglia.
    Var SR; Strell P; Johnson ST; Roman A; Vasilakos Z; Low WC
    Cell Transplant; 2023; 32():9636897231171001. PubMed ID: 37254858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy.
    Louboutin JP; Strayer DS
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.
    Du L; Zhang Y; Chen Y; Zhu J; Yang Y; Zhang HL
    Mol Neurobiol; 2017 Dec; 54(10):7567-7584. PubMed ID: 27830532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders.
    Tarale P; Alam MM
    Inflammopharmacology; 2022 Jun; 30(3):821-842. PubMed ID: 35290551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Microglia-based Therapeutic Approaches to Neurodegenerative Disorders.
    Zhang L; Wang Y; Liu T; Mao Y; Peng B
    Neurosci Bull; 2023 Mar; 39(3):491-502. PubMed ID: 36593381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Microglial Depletion Approaches in Pathological Condition of CNS.
    Tahmasebi F; Barati S
    Cell Mol Neurobiol; 2023 Aug; 43(6):2459-2471. PubMed ID: 36738403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ins and outs of microglial cells in brain health and disease.
    Pallarés-Moratalla C; Bergers G
    Front Immunol; 2024; 15():1305087. PubMed ID: 38665919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia dynamics in aging-related neurobehavioral and neuroinflammatory diseases.
    Javanmehr N; Saleki K; Alijanizadeh P; Rezaei N
    J Neuroinflammation; 2022 Nov; 19(1):273. PubMed ID: 36397116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enforced microglial depletion and repopulation as a promising strategy for the treatment of neurological disorders.
    Han J; Zhu K; Zhang XM; Harris RA
    Glia; 2019 Feb; 67(2):217-231. PubMed ID: 30378163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of Neuroinflammation-Modulating Strategies in Tuberculous Meningitis: Targeting Microglia.
    Lu HJ; Guo D; Wei QQ
    Aging Dis; 2024 May; 15(3):1255-1276. PubMed ID: 37196131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.